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Whole mount in situ hybridization
Background: Epispadias is the mildest phenotype of the human bladder exstrophy–epispadias complex
(BEEC), and presents with varying degrees of severity. This urogenital birth defect results from a disturbance
in the septation process, during which separate urogenital and anorectal components are formed through
division of the cloaca. This process is reported to be influenced by androgen signaling. The human PARM1
gene encodes the prostate androgen-regulated mucin-like protein 1, which is expressed in heart, kidney,
and placenta.
Methods: We performed whole mount in situ hybridization analysis of Parm1 expression in mouse embryos
between gestational days (GD) 9.5 and 12.5, which are equivalent to human gestational weeks 4–6. Since
the spatio-temporal localization of Parm1 corresponded to tissues which are affected in human epispadias,
we sequenced PARM1 in 24 affected patients.
Results: We found Parm1 specifically expressed in the region of the developing cloaca, the umbilical cord,
bladder anlage, and the urethral component of the genital tubercle. Additionally, Parm1 expression was
detected in the muscle progenitor cells of the somites and head mesenchyme. PARM1 gene analysis revealed
no alterations in the coding region of any of the investigated patients.
Conclusions: Thesefindings suggest that PARM1doesnot play amajor role in the development of human epispadias.
However, we cannot rule out the possibility that a larger sample size would enable detection of rare mutations in
this gene.© 2012 Elsevier B.V. All rights reserved.1. Introduction
Epispadias is the mildest phenotype of the human bladder
exstrophy–epispadias complex (BEEC), and presents with varying
degrees of severity. Previous research has implicated both environ-
mental and genetic factors in the development of the BEEC.
The non-steroidal androgen receptor antagonist flutamide (Flu;
2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide), which
is used to reduce androgen effects in patients with prostate cancer,plex; ER, endoplasmic reticulum;
mucin-like protein 1; UPR, ER
tu hybridization.
istry and Clinical Pharmacology,
onn, Germany. Tel.: +49 228
.
l rights reserved.has been shown to induce epispadias in male rat offspring, with a
peak incidence in animals whose mothers had received a single
oral dose on gestational day (GD) 16 (Foster and Harris, 2005).
This suggests that reduced androgen levels during early rat develop-
ment influence the formation of epispadias. In epispadias, migration
of the genital tubercle progenitor cells to the cloacal membrane is
disrupted, and this provokes failure of the ventral closure of the urethral
plate. The opening of the urethra is therefore located on the dorsal part
of the penis/clitoris or presents as open groove on the dorsum of the
penis.
Few data are available concerning the molecular processes under-
lying the role of reduced androgen levels in the formation of epis-
padias. However, we considered the prostate androgen-regulated
mucin-like protein 1 (PARM1) a promising candidate, since its regu-
lation is androgen-dependent, and it is involved in cellular responses
to environmental stress.
Fig. 1. Lateral views (left, A; right, A′) of a mouse embryo at GD7.5, showing Parm1
transcripts in the distal part of the anterior intestinal portal (aip) and extraembryonic
mesoderm (exmes). (B and B′) left and right views of an embryo at GD9.0 probed for
Parm1 expression. Parm1 expressing cells were found in the cephalic and circu-
mpharyngeal neural crest (head mesenchyme, hm), the dorsal parts of the somites
(so), the caudal lateral plate mesoderm and the yolk sac (ov), and in the cloacal mem-
brane (cm).
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tate and has been reported to be over-expressed in the regressing pros-
tate following androgen withdrawal (Bruyninx et al., 1999; Fladeby et
al., 2008). Previous studies have implicated human PARM1 in cell prolif-
eration and prostatic cell immortalization (Cornet et al., 2003), as well
as in murine adipocyte differentiation (Song et al., 2009). Recent re-
search has shown that PARM1 is a widely expressed protein, which is
localized to the endoplasmic reticulum (ER), Golgi, and plasma mem-
brane within the early endocytic pathway (Fladeby et al., 2008;
Isodono et al., 2010). Here, it is involved in ER stress-induced apoptosis
in the rat, which is similar to the function of its yeast ortholog Wsc4 in
the cellular response to environmental factors such as oxidative stress
and hypoxia (Zu et al., 2001). Wsc4 expression has been reported to
be cell-cycle regulated, with maximum levels occurring at mitosis
(Spellman et al., 1998) and, Wsc4 may play a role in protein trafficking
(Mamoun et al., 1999). PARM1 may have a similar function, as a previ-
ous study demonstrated its involvement in the ER stress/unfolded pro-
tein response (UPR) in rat cardiac myocytes, where it silenced
expression of Atf6 and Perk (Isodono et al., 2010). The UPR pathway is
activatedwhen an accumulation ofmisfolded and unfolded proteins in-
duces these proteins to aggregate, a process which results in cellular
toxicity (Kozutsumi et al., 1988). Signaling cascades induced by the
UPR response include the activating transcription factor 6 (ATF6) and
the eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3
or PERK) pathways. ATF6 is an ER stress-regulated transmembrane
transcription factor, which activates the transcription of the ER chaper-
one genes that promote correct folding and ER-associated protein deg-
radation. In contrast, PERK couples protein folding in the ER to
polypeptide biosynthesis by phosphorylating eIF2-alpha, thereby atten-
uating the initiation of translation in response to ER stress. Ultimately,
sustained ER stress leads to the activation of UPR initiated proapoptotic
pathways (Xu et al., 2005).
To our knowledge, no previous study has investigated the involve-
ment of PARM1 in the early development of the urogenital system.
We therefore performed whole mount in situ hybridization (WISH)
analyses in mice to investigate the expression of Parm1 between GD
9.5 and 12.5, which corresponds to human gestational weeks 4–6
(O'Rahilly, 1979). This timeframe represents the relevant stages of
external genital formation in both species (Wood et al., 2003). Local-
ization of mouse Parm1 expression was found within the anlage of
structures affected in human epispadias. This observation prompted
us to perform sequence analysis for mutations in PARM1 in 24 pa-
tients (16 males and 12 females) with isolated epispadias.
2. Materials and methods
2.1. Animals and in situ hybridization
Mouse embryos from wild type NMRI matings were dissected into
ice-cold phosphate buffered saline (PBS), fixed overnight in 4%
paraformaldehyde/PBS and then processed for in situ hybridization
as described byRichter et al. (2004). Digoxigenin (DIG)-labeled antisense
RNA probes were transcribed in vitro from a polymerase chain reaction
(PCR) product of murine Parm1 (nucleotides 215–523, GenBank acces-
sion number: NM_145562) containing a T7 promoter site at the 3′ end.
T7 RNA-polymerase, transcription buffer, and nucleotide mix (Promega,
Roche, Switzerland) were used in accordance with the manufacturer's
recommendations. Probes were purified using G-50 Sephadex columns
(GE-Healthcare Giles, UK). Images of whole embryos were obtained
using a Leica MZ16A dissecting microscope (Wetzlar, Germany), and
processed using Zeiss Axiovision software (Jena, Germany).
2.2. Histological analyses of mouse embryos
Following color development with nitro-blue tetrazolium chloride
(NBT)/5-bromo-4-chloro-3′-indolyphosphate p-toluidine salt (BCIP),embryos were post-fixed in 4% paraformaldehyde and embedded in
20% albumin/13% sucrose/0.5% gelatin/2.5% glutaraldehyde in a PBS
matrix. Vibratome sections were prepared with a thickness of 20 μm.
2.3. DNA sequencing
Blood samples were obtained from 24 patients with epispadias
(14 males and 10 females) and their relatives, following the provision
of written informed consent. All subjects were of self-reported Euro-
pean descent, reported an unremarkable family history, and had a
normal karyotype. The study was approved by the Ethics Committee
of the Medical Faculty of the University of Bonn.
2.4. DNA isolation and sequence analysis
Isolation of genomic DNA was carried out using the QIAmp DNA
Blood Kit (Qiagen, Hilden, Germany). Analysis of the human PARM1
gene (located on human chromosome 4q13.3) was performed using
PCR. PCR-amplified DNA products were subjected to direct automated
sequencing using a 3130XL Genetic Analyzer (Applied Biosystems,
Foster City, USA) in accordance with the manufacturer's specifica-
tions. PCR primers also served as sequencing primers. All primer se-
quences are available upon request. Direct sequencing generated
information concerning several single nucleotide polymorphisms
(SNPs; dbSNP Build136) in PARM1. Nucleotides were numbered
according to GenBank entry NM_015393.3.
3. Results
3.1. Analysis of Parm1 expression duringmidgestational mouse development
Parm1 expression first became evident at the early headfold stage
(GD 7.5–8.0). Transcripts were detected within the extraembryonic
mesoderm, as well as in the endoderm of the anterior intestinal pocket
and the dorsal midline endoderm (Fig. 1, A and A′). At GD 9.0–9.5,
Parm1 expressing cells were found in the cephalic and circu-
mpharyngeal neural crest, the dorsal aspect of the somites, the caudal
lateral plate mesoderm, the yolk sac, and in the cloacal membrane
Fig. 2. Expression of Parm1 during midgestional development of the mouse, as detected by whole-mount in situ hybridization. (A) Mouse embryo at GD9.5. Parm1 transcripts were
detected in the somites, cloacal membrane, and head mesenchyme. (B) Close-up of the caudal region of the embryo depicted in (A) showing Parm1 expression in the cloacal mem-
brane and the somites. (C) Schematic representation of a mouse embryo in frontal view. The red line illustrates the section plane of (F), (I) and (L). (D) Embryo of stage GD10.5
exhibiting strong Parm1 expression in the cloacal and umbilico-allantoic regions, in addition to the somites and head mesenchyme. The ventrocaudal expression domains are clearly
shown in the close-up (E) and the sagittal section (F) of the region. (G) In embryos at GD11.5, Parm1 transcripts are detected in the progenitor cells of the body musculature and
head mesenchyme. (H and I) Close-up and sagittal section of the genital region of the embryo depicted in (G), showing strong Parm1 expression in the ventral tail mesenchyme, the
urethral component of the genital tubercle, and in the umbilico-allantoic region comprising the bladder anlage. (J) Parm1 expression in an embryo at GD12.5, showing its somitic
and cephalic expression domains. (J and K) Close-up (K) and sagittal section (L) of the genital region of the embryo depicted in (J). Parm1 transcripts are found in the distal aspect of
the genital tubercle. Abbreviations: cm, cloacal membrane; fb, forelimb bud; gt, genital tubercle; hb, hindlimb bud; nt, neural tube; so, somite; uv, umbilical vessels.
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pression became more restricted during mid-gestational development
(GD 9.5–10.5, Fig. 2A, B, and D–F). Cephalic and circumpharyngeal
expression became focused to the diencephalic head mesenchyme sur-
rounding the eye-primordia, the midbrain–hindbrain region, and the
pharyngeal arch mesenchyme, and was detected at these locations
until GD 11.5 (Fig. 2G). At GD 12.5, cephalic Parm1 expression became
confined to the eye primordia (Fig. 2J). Within the somites, Parm1
expression became restricted to the dorsal and ventral lips of the der-
momyotome, and persisted in the muscle progenitor cells at all investi-
gated stages (Figs. 2A, D, G, and J). In the ventrocaudal trunk, strong
Parm1 transcriptional activity was detected in the tissues ventral to
the hindlimb bud, including the umbilico-allantoic region, the endo-
derm, and the ectoderm of the cloacal membrane, as well as the ventralectoderm and mesoderm along the tail including the ventral ectoder-
mal ridge. Thus Parm1 expressing regions in the caudal embryo during
midgestation (GD 9.5–10.5) comprised the progenitors of the urethra,
the genital tubercle, and the bladder.
With the emergence and development of the genital bud between
GD 11.5 and 12.5, urogenital expression of Parm1 became focused to
the urethral plate endoderm, with a stronger signal being detected
in the distal part of the urethral plate (Figs. 2G–L). On the basis of
this specific and restricted expression of Parm1 in the tissues contrib-
uting to the morphogenesis of the infraumbilical region – including
those of the external genitalia – and its previously established role
in androgen-dependent signaling, we hypothesized that PARM1 pro-
tein may be implicated in the occurrence of malformations of the ex-
ternal genitalia in humans.
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Examination of all PARM1 exons and their adjacent splice sites in the
24 patients revealed only two heterozygous variants. One very rare
non-synonymous c.G548A substitution predicting a p.Gly99Ser substi-
tution (dBSNP136: rs14492199) was found in a male patient and his
unaffected mother. An as yet unknown c.1101+9C>T substitution in
intron 3 was detected in another male patient, whose parents were
not available for screening. The following variants, which are common
SNPs that have been described previously (dbSNP Build136), were
also detected, and the number of the respective alleles is indicated in
brackets: rs75120017 (G,46/C,2); rs3822109 (C,26/T,22); rs3775527
(A,23/G,25); and rs1062293 (A,21/G,27). Similar haplotype data were
found in the European population of the International HapMap project,
the CEPH (Centre d'Etude du Polymorphisme Human) pedigrees, and
the PDR90 (The NIH Polymorphism Discovery Resource; 90 individual
screening) subset. For some listed SNPs (rs79974259, rs6836354,
rs35489484, rs34305542, rs11552358, rs34923973, rs62314892,
rs62314897), the nucleotide given in the reference sequence was only
detected in the homozygous state.
4. Discussion
Parm1 expression was first detected by Bruyninx et al. (1999) in
the ventral rat prostate. The authors demonstrated that Parm1
showed specific activity in the lower urogenital tract and displayed
androgen-regulated expression. In the present study, detailed expres-
sion analysis in the mouse embryo focused on the ventrocaudal trunk
region during developmental stages that are critical for the growth
and patterning of the external genitalia. Spatiotemporal analysis of
gene activity in the mouse embryo can provide important clues as
to the possible function of a gene in a given developmental process.
The results of the present WISH analysis support and extend the find-
ings of Ogaki et al. (2011), who recently detected Parm1 expression in
GD8.5 mouse definitive endoderm. At GD10.5, Parm1 transcripts were
detected in the pericardiac tissues, thus corroborating data from
Isodono et al. (2010), who reported on mRNA expression in hearts
of mouse embryos at this gestational age.
Our WISH data suggested that Parm1 is implicated in the develop-
ment of human epispadias. However, mutational analysis of the gene
in 24 epispadias patients identified only two variations in the coding
regions or exon-intron boundaries of PARM1. In one male patient a
p.Gly99Ser variant was observed, which was inherited from his unaf-
fected mother. This rare variant has recently been deposited into the
SNP database (rs14492199). Moreover, the program Mutation Taster
(www.mutationtaster.org), which evaluates the disease-causing po-
tential of a sequence alteration, predicted that it was a neutral vari-
ant. The c.1101+9C>T substitution in intron 3 observed in a
second male patient is also likely to be a benign variant. Interference
with splice site recognition appears unlikely, since estimation of the
consensus value (CV) (Shapiro and Senapathy, 1987) of this potential
new splice site yielded a CV of only 0.615, compared with the wil-
dtype CV of 0.911. Given these observations, genomic PARM1 muta-
tions are unlikely to be a frequent cause of human epispadias.
Although the present patient cohort may have been too small to de-
tect rare causal mutational events, the estimated birth prevalence
for epispadias is 1 in 117,000 in males and 1 in 484,000 in females
(Gearhart, 2002), and thus the sample size can be considered rela-
tively large. Furthermore, we cannot exclude the possibility that we
may have missed mutations in either the promoter region (in as yet
unknown regulatory sequences) or in non-coding regions which can-
not be detected with the method applied. In addition, dysfunction of
other factors involved in the regulation of PARM1 transcription may
also lead to differences in its expression. However, no RNA from the
patients was available for the performance of such expression analy-
ses. Furthermore, the extent to which such postnatal findings reflectthe situation during early embryonic development, when the mor-
phogenetic events leading to epispadias occur, awaits elucidation.
In summary, the present study showed that the Parm1 expression
domain is located in the vicinity of embryonic tissues involved in the
development of the urogenital system, and may thus have direct or
indirect effects on this process. This observation supported the hy-
pothesis that human PARM1 may be involved in the formation of
the defects observed in epispadias and the BEEC. However, our pre-
liminary mutation screening study did not detect PARM1 mutations
in patients with epispadias, although rare mutations might be detect-
able in larger patient samples. Future studies on the etiology of these
malformations should consider genes that encode other proteins in
the PARM1 signaling pathway as possible candidates.
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